Skip to content
Use caution Drug recall · FDA · Published December 16, 2024

FDC Limited Recalls Ciprofloxacin Eye Drops Due to Defective Caps

FDC Limited recalls 136,181 bottles of Ciprofloxacin Ophthalmic Solution because the cap spike is lodged in the nozzle, preventing use.

🇺🇸 FDA recall #D-0182-2025DrugFDC Limited ›
Take action

Contact the company

Recalling firmFDC LimitedB-8 MIDC Industrial Area, Waluj District · Aurangabad, Maharashtra State, India
✎ GovInfoNow plain-language explainer

FDC Limited is recalling Ciprofloxacin Ophthalmic Solution USP, 0.3% distributed by Leading Pharma LLC due to a manufacturing defect. The spike on the bottle cap is lodged in the nozzle, making it impossible to dispense the medication. This affects approximately 136,181 bottles sold nationwide. Read more at govinfonow.com/recall/32359-fdc-limited-recalls-ciprofloxacin-eye-drops-due-to-defective-caps.

Source Summary by GovInfoNow · govinfonow.com/recall/32359-fdc-limited-recalls-ciprofloxacin-eye-drops-due-to-defective-caps · Updated October 9, 2026 · FDA enforcement record: FDA #D-0182-2025

Cite this page

“FDC Limited Recalls Ciprofloxacin Eye Drops Due to Defective Caps.” GovInfoNow, updated October 9, 2026. https://govinfonow.com/recall/32359-fdc-limited-recalls-ciprofloxacin-eye-drops-due-to-defective-caps. Based on FDA recall #D-0182-2025 (https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0182-2025%22&limit=1).

The FDA announced on Dec. 16, 2024, that FDC Limited is recalling Ciprofloxacin Ophthalmic Solution due to defective containers that prevent the solution from being dispensed. The recall affects 136,181 bottles distributed nationwide.

How to tell if you have it

  • Brand: FDC Limited
  • Product: Ciprofloxacin Ophthalmic Solution USP, 0.3% as base, Sterile
  • Package: 5 mL bottles
  • NDC: 69315-308-05
  • Lots: 083L111 (Exp. 11/30/2025), 084A032 (Exp. 12/31/2025)
  • Distributor: Leading Pharma LLC, Fairfield, NJ
  • Quantity: 136,181 bottles

The hazard

The defective containers have spikes lodged in the nozzles, making it impossible to get the solution out of the bottle. The FDA classified this as a Class II recall.

Context

GovInfoNow's records show FDC Limited has issued 10 other recalls since April 25, 2024. Recent similar recalls include a July 5, 2025, Timolol Ophthalmic Solution recall for caps stuck in bottle nozzles and an April 18, 2025, Timolol Ophthalmic Solution 10mL recall for the same issue. Other recent recalls of similar products include a July 22, 2026, Micro Labs Dorzolamide/Timolol Eye Drops recall for broken caps and March 3, 2026, K.C. Pharmaceuticals recalls due to lack of sterility assurance.

How to tell if you have this one

Check if you have Ciprofloxacin Ophthalmic Solution USP, 0.3% in a 5 mL bottle distributed by Leading Pharma LLC (Fairfield, NJ). Look for NDC 69315-308-05 and check the lot numbers: 083L111 (Exp. 11/30/2025) or 084A032 (Exp. 12/31/2025). The defect is that the cap spike is lodged in the nozzle.

  • Brand
    FDC Limited
  • Category
    Drug
Based on the official FDA remedy

What to do — step by step

  1. Check Your Bottle

    Verify if your bottle matches the NDC, lot numbers (083L111 or 084A032), and expiration dates listed in the recall notice.

  2. Contact Your Pharmacy

    Since no specific remedy is stated in the record, contact the pharmacy where you purchased the item or Leading Pharma LLC for instructions on returns or replacements.

Where it went and when

Where it was distributed

Distributed nationwide.

Alaska: yesAKMaine: yesMEVermont: yesVTNew Hampshire: yesNHWashington: yesWAIdaho: yesIDMontana: yesMTNorth Dakota: yesNDMinnesota: yesMNIllinois: yesILWisconsin: yesWIMichigan: yesMINew York: yesNYRhode Island: yesRIMassachusetts: yesMAOregon: yesORNevada: yesNVWyoming: yesWYSouth Dakota: yesSDIowa: yesIAIndiana: yesINOhio: yesOHPennsylvania: yesPANew Jersey: yesNJConnecticut: yesCTCalifornia: yesCAUtah: yesUTColorado: yesCONebraska: yesNEMissouri: yesMOKentucky: yesKYWest Virginia: yesWVVirginia: yesVAMaryland: yesMDDelaware: yesDEArizona: yesAZNew Mexico: yesNMKansas: yesKSArkansas: yesARTennessee: yesTNNorth Carolina: yesNCSouth Carolina: yesSCDistrict of Columbia: yesDCOklahoma: yesOKLouisiana: yesLAMississippi: yesMSAlabama: yesALGeorgia: yesGAHawaii: yesHITexas: yesTXFlorida: yesFL

FDA distribution: “Nationwide” States read from FDA’s own wording; “not listed” means the notice does not name it.

Distributed nationwide.

Recall timeline

FDA published this recall 30 days after the firm started it.

1. Firm started the recall: Dec 16, 202412. FDA classified it Class II: Jan 3, 202523. Published in FDA’s Enforcement Report: Jan 15, 2025320242025
  1. Firm started the recall
  2. FDA classified it Class II
  3. Published in FDA’s Enforcement Report

Dates from the agency record only; steps without a date are left out.

Similar recalls

Latest drug recalls

Keep exploring

Where this comes from

The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.

  • Official source: FDA Recall #D-0182-2025 (December 16, 2024) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for D-0182-2025 to see it in context.
  • Plain-language summary written by qwen3.6:35b-a3b on October 9, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
  • GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.
GovInfoNow is an independent guide. We are not FDA or any government agency. Always confirm details with the official recall.Data: CPSC · FDA · NHTSA · USDA